Target Name: MMP15
NCBI ID: G4324
Review Report on MMP15 Target / Biomarker Content of Review Report on MMP15 Target / Biomarker
MMP15
Other Name(s): matrix metallopeptidase 15 (membrane-inserted) | Matrix metalloproteinase-15 | membrane-type matrix metalloproteinase 2 | MMP-15 | SMCP-2 | Matrix metalloproteinase 15 (membrane-inserted) | MMP15_HUMAN | MT2MMP | Membrane-type-2 matrix metalloproteinase | membrane-type-2 matrix metalloproteinase | Matrix metallopeptidase 15 | MT2-MMP | matrix metalloproteinase 15 (membrane-inserted) | MTMMP2 | MT-MMP 2 | Membrane-type matrix metalloproteinase 2 | matrix metallopeptidase 15

Understanding MMP15: Serine Proteases and Extracellular Matrix Breakdown

MMP15, also known as matrix metallopeptidase 15, is a protein that is expressed in a variety of cell types throughout the body. It is a member of the serine proteases group 15, which includes enzymes that play a critical role in the breakdown of extracellular matrix (ECM) components. ECM is a complex mixture of carbohydrates, proteins, and other molecules that are arranged in a specific pattern in the body's tissues and organs. MMP15 is involved in the breakdown of ECM, which is essential for cell growth, migration, and adhesion.

MMP15 is a transmembrane protein, which means that it spans the cell membrane and is involved in the extracellular matrix. It is composed of a catalytic active center and a transmembrane region. The catalytic active center is responsible for the breakdown of ECM components, while the transmembrane region is involved in the regulation of the activity of the enzyme.

MMP15 is involved in a wide range of physiological processes in the body. It is involved in the development and maintenance of tissues and organs, as well as in the regulation of cell growth, differentiation, and survival. It is also involved in the regulation of the immune response and in the regulation of inflammation.

Despite its involvement in many important physiological processes, MMP15 is a relatively small protein with only 115 amino acid residues. This has made it an attractive target for researchers to study and develop new drugs.

One of the challenges in studying MMP15 is its complex structure. As a transmembrane protein, it is involved in the regulation of the activity of the enzyme and is located at the interface between the cytosol and the cell membrane. This makes it difficult to study the molecular mechanisms that are responsible for its function.

In addition, MMP15 is a potent inhibitor of the enzyme collagenase, which is involved in the breakdown of ECM. This makes it difficult to study the effects of MMP15 on collagenase activity and the role it plays in the regulation of ECM.

Despite these challenges, research into MMP15 has led to several important discoveries. For example, it was shown that MMP15 is involved in the regulation of cell migration and that it plays a role in the development of cancer. Additionally, studies have shown that MMP15 is involved in the regulation of the immune response and that it is involved in the regulation of inflammation.

In conclusion, MMP15 is a protein that is involved in the breakdown of extracellular matrix components and is expressed in a variety of cell types throughout the body. It is a potential drug target and a promising biomarker for a variety of diseases. Further research is needed to fully understand the molecular mechanisms that are responsible for its function and to develop new treatments based on its properties.

Protein Name: Matrix Metallopeptidase 15

Functions: Endopeptidase that degrades various components of the extracellular matrix. May activate progelatinase A

The "MMP15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK | MON1A | MON1B | MON2 | Monoamine oxidase (MAO) | Monoamine Transporter (MAT) | MORC1 | MORC2 | MORC2-AS1 | MORC3 | MORC4 | MORF4 | MORF4L1 | MORF4L1P1 | MORF4L1P3 | MORF4L1P7 | MORF4L2 | MORF4L2-AS1 | MORN1 | MORN2 | MORN3 | MORN4 | MORN5 | MOS | MOSMO | MOSPD1 | MOSPD2 | MOSPD3 | MOV10 | MOV10L1 | MOXD1 | MOXD2P | MPC1 | MPC2 | MPDU1 | MPDU1-AS1 | MPDZ | MPEG1 | MPG | MPHOSPH10 | MPHOSPH10P1 | MPHOSPH6 | MPHOSPH8 | MPHOSPH9